Subscribe
Subscribe
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.
Picture of BioVox

BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is powered by Biovia: the health innovation cluster for Flanders.

ThromboGenics starts Diabetic Macular Edema trial phase II

Novosanis closes third round of seed funding

Promethera Biosciences and LifeLiver Sign Alliance

IP strategy for oligonucleotides

MDxHealth Announces Preliminary Update on 2016 Results and Appointment of CFO

Continued coverage of Celyad’s Patent assured

argenx launches Phase II study of ARGX-113 for the treatment of myasthenia gravis

$41 Million raised for a biotech start-up by founders without biotech background

CRISPR start-up Synthego raises $41 million

Bone Therapeutics Granted EUR 2.3 Million by the Walloon Region

Bone cell therapy company Bone Therapeutics receives 2.3 million in funding from the Wallonian Government.

Celyad Announces Registration of the first patient in the Belgian THINK trial

Celyad commences THINK trial with its cell-based CAR-T/NKR-2 immunotherapy 

Ablynx to present at the 35th annual J.P. Morgan Healthcare Conference

Ablynx will present at the 35th Annual J.P. Morgan Healthcare Conference on Thursday 12 January, at 1.30 am CET (Wednesday 11 January 2017 at 4:30 p.m. PST).

$12 million for Univercells’s vaccines

Cystic Fibrosis research projects wanted!

Call for research grants by Fund Alphonse & Jean Forton, managed by the King Baudouin Foundation, and Belgian Cystic Fibrosis Association.

CRISPR companies sharing IPO, will they get along?

Some of the biggest CRISPR-using companies have created an IP-sharing alliance on their technology. CRISPR Therapeutics, Intellia, Caribou Biosciences and ERS Genomics have banded together in an effort to protect their IP as a team. The companies rely on patents held by UC Berkley, Emmanuelle Charpentier (one of the main pioneers in the CRISPR field) and the University of Vienna.

ULg receives WHO prequalifaction for drug control

After being the first European university to receive the GMP (Good Manufacturing Practices) certification for the quality control of drugs in 2014, ULg is now also the first university in the world to be prequalified by the WHO (World Health Organization).